Xueli L. Tian

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

A multicohort machine-learning prognostic signature reveals inflammatory immune remodeling and statin sensitivity in glioblastoma.

A multicohort machine-learning prognostic signature reveals inflammatory immune remodeling and statin sensitivity in glioblastoma.

Journal: Frontiers in oncology
Published: June 17, 2026

Correction: CMTM6 drives glioblastoma progression by promoting M2 polarization and suppressing antigen presentation in microglia/macrophages.

Correction: CMTM6 drives glioblastoma progression by promoting M2 polarization and suppressing antigen presentation in microglia/macrophages.

Journal: European journal of medical research
Published: March 06, 2026

The Roles of TOPK in Tumorigenesis and Development: Structure, Mechanisms, Pathways, and Therapeutic Implications.

The Roles of TOPK in Tumorigenesis and Development: Structure, Mechanisms, Pathways, and Therapeutic Implications.

Journal: International journal of biological sciences
Published: August 02, 2025

CMTM6 drives glioblastoma progression by promoting M2 polarization and suppressing antigen presentation in microglia/macrophages.

CMTM6 drives glioblastoma progression by promoting M2 polarization and suppressing antigen presentation in microglia/macrophages.

Journal: European journal of medical research
Published: July 14, 2025

INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma.

INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma.

Journal: Nature communications
Published: August 06, 2024

Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis.

Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 21, 2023

Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint.

Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint.

Journal: Frontiers in immunology
Published: January 15, 2023

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 12, 2023

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity.

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity.

Journal: Frontiers in pharmacology
Published: August 26, 2022

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer.

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer.

Journal: Molecular cancer
Published: July 28, 2022

Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19.

Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19.

Journal: Signal transduction and targeted therapy
Published: May 06, 2022

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Journal: Signal transduction and targeted therapy
Published: April 27, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026